Deletions of the P. falciparum genes for the HRP2 and HRP3 antigens can compromise the performance of HRP2/3-based RDTs and adversely affect malaria healthcare delivery in a nation like Haiti which relies strongly on RDTs for detection of P. falciparum infection. The gene discussed is HDGFL3; the disease is malaria.